American Society of Addiciton Medicine
Aug 9, 2021 Reporting from Rockville, MD
ASAM and VASAM submit comments on the Virginia Board of Medicine's on the proposed regulations, Governing Opioid Prescribing for Pain and Prescribing of Buprenorphine for Office-Based Opioid Addiction Treatment
https://www.asam.org/news/detail/2021/08/09/asam-and-vasam-submit-comments-on-the-virginia-board-of-medicine's-on-the-proposed-regulations-governing-opioid-prescribing-for-pain-and-prescribing-of-buprenorphine-for-office-based-opioid-addiction-treatment
Aug 9, 2021
ASAM and the Virginia Society of Addiciton Medicine (VASAM) sent a letter to the Virginia Board of Medicine commenting on the proposed regulations, Governing Opioid Prescribing for Pain and Prescribing of Buprenorphine for Office-Based Opioid Addiction Treatment.

ASAM and VASAM submit comments on the Virginia Board of Medicine's on the proposed regulations, Governing Opioid Prescribing for Pain and Prescribing of Buprenorphine for Office-Based Opioid Addiction Treatment .Substring(0, maxlength)

American Society of Addictin Medicine

News

ASAM and VASAM submit comments on the Virginia Board of Medicine's on the proposed regulations, Governing Opioid Prescribing for Pain and Prescribing of Buprenorphine for Office-Based Opioid Addiction Treatment

Aug 9, 2021

PDF

 

ASAM and the Virginia Society of Addiciton Medicine (VASAM) sent a letter to the Virginia Board of Medicine commenting on the proposed regulations, Governing Opioid Prescribing for Pain and Prescribing of Buprenorphine for Office-Based Opioid Addiction Treatment.